Æȷοì
Tracy Robson
Tracy Robson
rcsi.ieÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
The concise guide to pharmacology 2021/22: Enzymes
SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ...
British journal of pharmacology 178, S313-S411, 2021
3662021
Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance
MC Joiner, P Lambin, EP Malaise, T Robson, JE Arrand, KA Skov, ...
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 358 (2 ¡¦, 1996
3561996
Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery
HO McCarthy, J McCaffrey, CM McCrudden, A Zholobenko, AA Ali, ...
Journal of Controlled Release 189, 141-149, 2014
2112014
Transcriptional targeting in cancer gene therapy
T Robson, DG Hirst
Journal of Biomedicine and Biotechnology 2003 (2), 110, 2003
1672003
Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells
AL Dunne, ME Price, C Mothersill, SR McKeown, T Robson, DG Hirst
British journal of cancer 89 (12), 2277-2283, 2003
1562003
Nitric oxide physiology and pathology
DG Hirst, T Robson
Nitric Oxide: Methods and Protocols, 1-13, 2011
1552011
Nitric oxide—a novel therapeutic for cancer
JA Coulter, HO McCarthy, J Xiang, W Roedl, E Wagner, T Robson, ...
Nitric oxide 19 (2), 192-198, 2008
1372008
Targeting nitric oxide for cancer therapy
D Hirst, T Robson
Journal of Pharmacy and Pharmacology 59 (1), 3-13, 2007
1362007
Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
LH Patterson, SR McKeown, T Robson, R Gallagher, SM Raleigh, S Orr
Anti-Cancer Drug Design 14 (6), 473-486, 1999
1171999
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles
AA Ali, CM McCrudden, J McCaffrey, JW McBride, G Cole, NJ Dunne, ...
Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 921-932, 2017
1022017
Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives
G Moore, S Annett, L McClements, T Robson
Cells 9 (6), 1503, 2020
1002020
Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy
D Hirst, T Robson
Current pharmaceutical design 16 (4), 411-420, 2010
982010
Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents
H Lohrer, T Robson
Carcinogenesis 10 (12), 2279-2284, 1989
891989
Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents
H Lohrer, T Robson
Carcinogenesis 10 (12), 2279-2284, 1989
891989
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno‐and phenotype
KT Butterworth, HO McCarthy, A Devlin, L Ming, T Robson, SR McKeown, ...
International Journal of Cancer 123 (4), 760-768, 2008
882008
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
JK Dowling, R Afzal, LJ Gearing, MP Cervantes-Silva, S Annett, GM Davis, ...
Nature communications 12 (1), 1460, 2021
852021
Targeting cancer stem cells in the clinic: Current status and perspectives
S Annett, T Robson
Pharmacology & therapeutics 187, 13-30, 2018
822018
Nitrosative stress in cancer therapy
DG Hirst, T Robson
Front Biosci 12, 3406-3418, 2007
822007
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells
C Adams, HO McCarthy, JA Coulter, J Worthington, C Murphy, T Robson, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on ¡¦, 2009
802009
DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system
G Cole, AA Ali, CM McCrudden, JW McBride, J McCaffrey, T Robson, ...
European Journal of Pharmaceutics and Biopharmaceutics 127, 288-297, 2018
792018
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20